Find Galantamine Hydrobromide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Galanthamine hydrobromide, 1953-04-4, Reminyl, Nivalin, Nivaline, Razadyne
Molecular Formula
C17H22BrNO3
Molecular Weight
368.3  g/mol
InChI Key
QORVDGQLPPAFRS-XPSHAMGMSA-N
FDA UNII
MJ4PTD2VVW

Galantamine Hydrobromide
A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders.
1 2D Structure

Galantamine Hydrobromide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol;hydrobromide
2.1.2 InChI
InChI=1S/C17H21NO3.BrH/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17;/h3-6,12,14,19H,7-10H2,1-2H3;1H/t12-,14-,17-;/m0./s1
2.1.3 InChI Key
QORVDGQLPPAFRS-XPSHAMGMSA-N
2.1.4 Canonical SMILES
CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O.Br
2.1.5 Isomeric SMILES
CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O.Br
2.2 Other Identifiers
2.2.1 UNII
MJ4PTD2VVW
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Galantamin

2. Galantamine

3. Galanthamine

4. Galanthamine Hydrobromide

5. Lycoremine

6. Nivalin

7. Nivaline

8. Razadyne

9. Reminyl

2.3.2 Depositor-Supplied Synonyms

1. Galanthamine Hydrobromide

2. 1953-04-4

3. Reminyl

4. Nivalin

5. Nivaline

6. Razadyne

7. Lycoremine Hydrobromide

8. Jilkon Hydrobromide

9. Galanthamine (hydrobromide)

10. Galanthamine Hbr

11. Tamilin

12. 193146-85-9

13. Mj4ptd2vvw

14. 5n4sa4kqx9

15. (-)-galantamine Hydrobromide

16. (+/-)-galantamine Hydrobromide

17. (+/-)-galanthamine Hydrobromide

18. Galantamine Hydrobromide (racemic)

19. Galantamine Hydrobromide, (+/-)-

20. (1s,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol;hydrobromide

21. (4as,6r,8as)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6h-benzofuro[3a,3,2-ef][2]benzazepin-6-ol Hydrobromide

22. Razadyne Er

23. Reminyl (tn)

24. (1s,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azoniatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol;bromide

25. (4as,6r,8as)-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6h-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol Hydrobromide

26. Galanthaminehydrobromide

27. 1953-04-4 (hbr); 1953-04-4 (free Base).

28. (1s,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-14-ol Hydrobromide

29. (4as,6r,8as)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6h-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol Hydrobromide

30. 6h-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, Hydrobromide (1:1), (4ar,6s,8ar)-rel-

31. 6h-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, Hydrobromide (1:1), (4as,6r,8as)-

32. Smr000449267

33. Sr-01000597844

34. Nivaline (pharmaceutical)

35. C17h22brno3

36. Anti-alzheimer

37. Sr-05000001783

38. Nivalin;razadyne

39. Galantamine Hydrobromide [usan]

40. Reminyl Xl

41. Jilcon Hydrobromide

42. Razadyne (tn)

43. Prestwick_236

44. Einecs 217-780-5

45. Galanthamine Hydrobromide From Lycoris Sp.

46. Mfcd00067672

47. Unii-mj4ptd2vvw

48. Unii-5n4sa4kqx9

49. 1953-04-4 Unlabeled

50. Chembl1555

51. Galanthamine-d3 Hydrobromide

52. Mls000758283

53. Mls001401401

54. Galanthamine Hydrobromide,(s)

55. Schembl177993

56. Spectrum1501202

57. Hms1569f18

58. Hms1921p21

59. Hy-a0009

60. Galantamine Hydrobromide (jan/usp)

61. Ac-469

62. Ccg-38829

63. Galantamine Hydrobromide [mi]

64. Galantamine Hydrobromide [usan:usp]

65. S1339

66. Galantamine Hydrobromide [jan]

67. Galanthamine-o-methyl-d3 Hydrobromide

68. Akos007930166

69. Akos015960209

70. Cs-0378

71. Fd10095

72. Galantamine Hydrobromide [hsdb]

73. Nc00061

74. Galantamine Hydrobromide [mart.]

75. Galantamine Hydrobromide [vandf]

76. Galantamine Hydrobromide [usp-rs]

77. Galantamine Hydrobromide [who-dd]

78. 6h-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, Hydrobromide, (4as,6r,8as)-

79. As-12155

80. Gp-37267

81. G0293

82. Galantamine Hydrobromide [orange Book]

83. D02173

84. Galantamine Hydrobromide [ep Monograph]

85. Galantamine Hydrobromide [usp Monograph]

86. Galantamine Hydrobromide Racemic [usp-rs]

87. 953g044

88. A866857

89. A903748

90. R-113675

91. Sr-01000597844-1

92. Sr-01000597844-5

93. Sr-05000001783-3

94. Q47495772

95. Z1558572528

96. Galanthamine Hydrobromide From Lycoris Sp., >=94% (tlc)

97. (4as,6r,8as)-3-methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4ah-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol Hydrobromide

98. (4as,6r,8as)-3-methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4ah-benzo[2,3]benzofuro[4,3-cd]azepin-6-olhydrobromide

99. (4as,6r,8as)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6h-benzofuro[3a,3,2-ef][2]benzazepin-6-ol, Hydrobromide

100. (4as,6r,8as)-4a,5,9,10,11,12-hexahydro-3-methoxy-d3-11-methyl-6h-benzofuro[3a,3,2-ef][2]benzazepin-6-ol Hydrobromide

101. 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6h-benzofuro[3a,3,2-ef][2]benzazepin-6-ol Hydrobromide

102. 6h-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, Hbr (1:1), (4as,6r,8as)-

103. 6h-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, Hbr, (4as,6r,8as)-

104. 6h-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, Hydrobromide, (4a.alpha.,6.beta.,8ar*)-

105. 6h-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, Hydrobromide, (4aalpha,6beta,8ar*)-

2.3.3 Other Synonyms

1. Galantamine

2. Galanthamine Hydrobromide

3. Lycoremin

4. Lycoremine

5. Nivalin

6. Razadyne

7. Reminyl

8. Galanthamine

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 368.3 g/mol
Molecular Formula C17H22BrNO3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count1
Exact Mass367.07831 g/mol
Monoisotopic Mass367.07831 g/mol
Topological Polar Surface Area41.9 Ų
Heavy Atom Count22
Formal Charge0
Complexity440
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameGalantamine hydrobromide
PubMed HealthGalantamine (By mouth)
Drug ClassesCentral Nervous System Agent
Drug LabelGalantamine hydrobromide is a reversible, competitive acetylcholinesterase inhibitor. Galantamine hydrobromide is known chemically as (4aS,6R,8aS)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro [3a,3,2-ef][2]benzazepin-6-ol hydrobromide....
Active IngredientGalantamine hydrobromide
Dosage FormTablet; Capsule, extended release; Solution
Routeoral; Oral
Strengtheq 4mg base; 8mg; eq 12mg base; 4mg; 4mg/ml; 12mg; eq 16mg base; eq 24mg base; eq 8mg base
Market StatusTentative Approval; Prescription
CompanyRanbaxy; Apotex; Aurobindo Pharma; Sun Pharm Inds; Sandoz; Sun Pharma Global; Roxane; Watson Labs; Teva Pharms; Zydus Pharms Usa; Dr Reddys Labs; Mylan; Impax Labs; Barr

2 of 4  
Drug NameRazadyne
Drug LabelRAZADYNE ER/RAZADYNE (galantamine hydrobromide) is galantamine hydrobromide, a reversible, competitive acetylcholinesterase inhibitor. Galantamine hydrobromide is known chemically as (4aS ,6R,8aS )-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H...
Active IngredientGalantamine hydrobromide
Dosage FormTablet; Solution
RouteOral
Strengtheq 4mg base; eq 12mg base; 4mg/ml; eq 8mg base
Market StatusPrescription
CompanyJanssen Pharms

3 of 4  
Drug NameGalantamine hydrobromide
PubMed HealthGalantamine (By mouth)
Drug ClassesCentral Nervous System Agent
Drug LabelGalantamine hydrobromide is a reversible, competitive acetylcholinesterase inhibitor. Galantamine hydrobromide is known chemically as (4aS,6R,8aS)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro [3a,3,2-ef][2]benzazepin-6-ol hydrobromide....
Active IngredientGalantamine hydrobromide
Dosage FormTablet; Capsule, extended release; Solution
Routeoral; Oral
Strengtheq 4mg base; 8mg; eq 12mg base; 4mg; 4mg/ml; 12mg; eq 16mg base; eq 24mg base; eq 8mg base
Market StatusTentative Approval; Prescription
CompanyRanbaxy; Apotex; Aurobindo Pharma; Sun Pharm Inds; Sandoz; Sun Pharma Global; Roxane; Watson Labs; Teva Pharms; Zydus Pharms Usa; Dr Reddys Labs; Mylan; Impax Labs; Barr

4 of 4  
Drug NameRazadyne
Drug LabelRAZADYNE ER/RAZADYNE (galantamine hydrobromide) is galantamine hydrobromide, a reversible, competitive acetylcholinesterase inhibitor. Galantamine hydrobromide is known chemically as (4aS ,6R,8aS )-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H...
Active IngredientGalantamine hydrobromide
Dosage FormTablet; Solution
RouteOral
Strengtheq 4mg base; eq 12mg base; 4mg/ml; eq 8mg base
Market StatusPrescription
CompanyJanssen Pharms

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Nootropic Agents

Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)


Cholinesterase Inhibitors

Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)


Parasympathomimetics

Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (See all compounds classified as Parasympathomimetics.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Cholinesterase Inhibitors [MoA]; Cholinesterase Inhibitor [EPC]

API SUPPLIERS

read-more
read-more

01

Capital Farma

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCapital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.

Flag Spain
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF EDQM Cer... arrow-down AUDIT
Capital Farma

02

Metrochem API Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
Metrochem

03

Nuray Chemicals Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Nuray Chemicals

04

Dr. Reddy's Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Product Not Available For Sales

USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT arrow-down
Dr Reddy Company Banner

05

HRV Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU arrow-down AUDIT
HRV Global Life Sciences

06

Indena

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothIndena - Advancing botanical science with a century of innovation, quality, and trusted global expertise.

Flag Italy
Digital Content Digital Content
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
Company Banner

07

ScinoPharm Taiwan Ltd

Taiwan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

ScinoPharm Taiwan Ltd

Taiwan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

08

ScinoPharm Taiwan Ltd

Taiwan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

ScinoPharm Taiwan Ltd

Taiwan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

09

ZHEJIANG YIXIN PHARMACEUTICAL CO L...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

ZHEJIANG YIXIN PHARMACEUTICAL CO L...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Sun Pharmaceutical Industries Limi...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

Sun Pharmaceutical Industries Limi...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-moreread-more
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothIndena - Advancing botanical science with a century of innovation, quality, and trusted global expertise.

Flag Italy
Digital Content Digital Content
R1-CEP 2011-288 - Rev 01
Valid
Chemical
2020-11-19
2366
Company Banner

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothIndena - Advancing botanical science with a century of innovation, quality, and trusted global expertise.

Flag Italy
Digital Content Digital Content

Certificate Number : R1-CEP 2011-288 - Rev 01

Status : Valid

Issue Date : 2020-11-19

Type : Chemical

Substance Number : 2366

Company Banner

02

PEGS Boston Summit
Not Confirmed
arrow

03

PEGS Boston Summit
Not Confirmed
arrow

04

PEGS Boston Summit
Not Confirmed
arrow

05

PEGS Boston Summit
Not Confirmed
arrow

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Certificate Number : R1-CEP 2012-328 - Rev 00

Status : Withdrawn by Holder

Issue Date : 2019-03-07

Type : Chemical

Substance Number : 2366

blank

07

PEGS Boston Summit
Not Confirmed
arrow

08

PEGS Boston Summit
Not Confirmed
arrow

GALEN-N EOOD Sofia BG

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
CEP 2024-450 - Rev 00
Valid
Chemical
2026-03-19
2366
blank

09

GALEN-N EOOD Sofia BG

Country
PEGS Boston Summit
Not Confirmed
arrow

GALEN-N EOOD Sofia BG

Country
arrow
PEGS Boston Summit
Not Confirmed

Certificate Number : CEP 2024-450 - Rev 00

Status : Valid

Issue Date : 2026-03-19

Type : Chemical

Substance Number : 2366

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCapital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.

Flag Spain
Digital Content Digital Content

Galantamine Hydrobromide

About the Company : Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharmaceutical Ingredients (APIs) sourced from leading European manufacturers. The co...

Capital Farma provides integrated pharmaceutical solutions with a focus on high-quality Active Pharmaceutical Ingredients (APIs) sourced from leading European manufacturers. The company co-develops proprietary APIs with established European Contract Manufacturing Organizations (CMOs) and offers complete product packages by combining APIs with Finished Dosage Form (FDF) dossiers. Capital Farma also supports market expansion through FDF licensing services, enabling partners to access new regions efficiently. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Capital Farma

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

Galanthamine

About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
Metrochem

03

HRV Pharma

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Galantamine

About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...

HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing, manufacturing, and supply services to support partners entering new markets worldwide. HRV Pharma works closely with major pharma and food additive companies and represents over 30 Indian drugmakers, primarily serving Europe, the US, and the Middle East. Headquartered in India, it operates offices in the US, Switzerland, Dubai, Lithuania, and Turkey. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
HRV Global Life Sciences

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Galanthamine

About the Company : Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company comme...

Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.
blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Galanthamine

About the Company : Jubilant Life Sciences Limited, is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmace...

Jubilant Life Sciences Limited, is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients. It also provides services in Contract Manufacturing of Sterile Injectables and Drug Discovery and Development. The Company’s strength lies in its unique offerings of Pharmaceutical and Life Sciences products and services across the value chain. Our success is an outcome of strategic focus on the pharmaceuticals and life sciences industry, moving up the pharmaceutical value chain for products.
blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Galanthamine

About the Company : Nanjing Bold Chemical Co., Ltd. is a high-tech enterprise dedicated to product development, production, sales and supply chain management in the field of pharmaceutical chemistry. ...

Nanjing Bold Chemical Co., Ltd. is a high-tech enterprise dedicated to product development, production, sales and supply chain management in the field of pharmaceutical chemistry. Our products and services mainly include a full range of functional pharmaceutical excipients, APIs, pharmaceutical intermediates, custom synthesis of new chemical substances and other related fields. Designed to provide customers globally with systematic product resources. We are available in various pharmaceutical excipients, APIs and pharmaceutical intermediates that comply with USP, EP, JP, and ChP standards.
blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Galantamine Hydrobromide

About the Company : Nortec Química stands as the largest manufacturer of Active Pharmaceutical Ingredients (IFAs) in Latin America, embarking on its mission to ensure the availability of quality medi...

Nortec Química stands as the largest manufacturer of Active Pharmaceutical Ingredients (IFAs) in Latin America, embarking on its mission to ensure the availability of quality medicines with IFAs developed in Brazil. The company's approach involves leveraging the expertise of major National Research Centers and tapping into the experience of the Brazilian Chemical and Petrochemical Industry. Nortec Química plays a significant role in the Brazilian pharmaceutical landscape and the Unified Health System (SUS), producing APIs for branded, generic, and similar medicines, as well as medicines dedicated to addressing neglected diseases.
blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Galantamine Hydrobromide

About the Company : Pellets Pharma Limited is a fast growing organization established by a team of professionals with over decades of experience in the pharmaceutical industry with specific reference ...

Pellets Pharma Limited is a fast growing organization established by a team of professionals with over decades of experience in the pharmaceutical industry with specific reference to the development and manufacture of various modified release solid oral dosage forms. The company’s forte is the customized development and manufacturing of Modified Release Pellets / Retard Micro Granules of various Active Pharmaceutical Ingredients (APIs) including different combination blends in Ready - To - Fill form. The facility is designed to meet the regulatory requirements inline with the cGMP norms.
blank

09

Polaris AI Pharma

South Korea
PEGS Boston Summit
Not Confirmed
arrow

Polaris AI Pharma

South Korea
arrow
PEGS Boston Summit
Not Confirmed

Galantamine Hydrobromide

About the Company : Polaris AI Pharma is a dynamic company specializing in innovative pharmaceutical solutions. Leveraging cutting-edge AI technology, it focuses on drug discovery, development, and op...

Polaris AI Pharma is a dynamic company specializing in innovative pharmaceutical solutions. Leveraging cutting-edge AI technology, it focuses on drug discovery, development, and optimization to address unmet medical needs. Committed to advancing healthcare, Polaris AI Pharma combines scientific expertise with digital innovation to deliver impactful treatments.
blank

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Galanthamine

About the Company : ScinoPharm Taiwan Ltd. is a leading process R&D and API manufacturing service provider to the global pharmaceutical industry. With cGMP production facilities, ScinoPharm offers a w...

ScinoPharm Taiwan Ltd. is a leading process R&D and API manufacturing service provider to the global pharmaceutical industry. With cGMP production facilities, ScinoPharm offers a wide portfolio of services ranging from custom synthesis for early phase pharmaceutical activities to brand companies as well as APIs for the generic industry.Combining cost-effective resources and productivity of Asia along with unmatched regulatory know-how, ScinoPharm is uniquely positioned to serve global pharmaceutical R&D and manufacturing needs at any level and for any company in this sector.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Galantamine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Galantamine Hydrobromide,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 13, 2011

Dr Reddy Company Banner

01

Lead Product(s) : Galantamine Hydrobromide,Inapplicable

Therapeutic Area : Undisclosed

Highest Development Status : Phase I

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Galantamine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 13, 2011

Dr Reddy Company Banner

Details:

Reminyl (Galantamine) is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Feeding and Eating Disorders.


Lead Product(s): Galantamine Hydrobromide,Inapplicable

Therapeutic Area: Psychiatry/Psychology Brand Name: Reminyl

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 13, 2011

Dr Reddy Company Banner

02

Lead Product(s) : Galantamine Hydrobromide,Inapplicable

Therapeutic Area : Psychiatry/Psychology

Highest Development Status : Phase I

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Reminyl (Galantamine) is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Feeding and Eating Disorders.

Product Name : Reminyl

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 13, 2011

Dr Reddy Company Banner
  • Development Update

Details:

Galantamine HBr is a Miscellaneous drug candidate, which is currently being evaluated in Phase II/ Phase III clinical studies for the treatment of Spinal Cord Injuries.


Lead Product(s): Galantamine Hydrobromide,Inapplicable

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: Undisclosed

Study Phase: Phase II/ Phase IIIProduct Type: Miscellaneous

Sponsor: Bronx Veterans Medical Research Foundation, Inc | Kessler Institute for Rehabilitation

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 04, 2026

blank

03

Northwell Health

Country
arrow
PEGS Boston Summit
Not Confirmed

Northwell Health

Country
arrow
PEGS Boston Summit
Not Confirmed

Lead Product(s) : Galantamine Hydrobromide,Inapplicable

Therapeutic Area : Trauma (Emergency, Injury, Surgery)

Highest Development Status : Phase II/ Phase III

Partner/Sponsor/Collaborator : Bronx Veterans Medical Research Foundation, Inc | Kessler Institute for Rehabilitation

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Galantamine HBr is a Miscellaneous drug candidate, which is currently being evaluated in Phase II/ Phase III clinical studies for the treatment of Spinal Cord Injuries.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 04, 2026

blank

Details:

Galantamine HBr, a miscellaneous product targeting acetylcholinesterase, shows promise in treating sarcopenia.


Lead Product(s): Galantamine Hydrobromide,Metformin

Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 01, 2026

blank

04

PEGS Boston Summit
Not Confirmed
PEGS Boston Summit
Not Confirmed

Details : Galantamine HBr, a miscellaneous product targeting acetylcholinesterase, shows promise in treating sarcopenia.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 01, 2026

blank
  • Development Update

Details:

Mononuclear Cell is a Cell & Gene Therapy drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of Alzheimer Disease.


Lead Product(s): Mononuclear Cell,Donepezil,Rivastigmine,Galantamine Hydrobromide

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Cell & Gene Therapy

Sponsor: Shandong Qilu Stem Cell Engineering Co., Ltd.

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 06, 2025

blank

05

Anhui Provincial Hospital

Country
arrow
PEGS Boston Summit
Not Confirmed

Anhui Provincial Hospital

Country
arrow
PEGS Boston Summit
Not Confirmed

Lead Product(s) : Mononuclear Cell,Donepezil,Rivastigmine,Galantamine Hydrobromide

Therapeutic Area : Neurology

Highest Development Status : Phase I

Partner/Sponsor/Collaborator : Shandong Qilu Stem Cell Engineering Co., Ltd.

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Mononuclear Cell is a Cell & Gene Therapy drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of Alzheimer Disease.

Product Name : Undisclosed

Product Type : Cell & Gene Therapy

Upfront Cash : Inapplicable

October 06, 2025

blank

Details:

RJx-01 is a combination of galantamine and metformin, works by inhibiting AChE and acting as an allosteric modulator of nAChRs, being investigated for COPD-related muscle weakness.


Lead Product(s): Galantamine Hydrobromide,Metformin

Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: National Institute for Health and Care Research

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 19, 2025

blank

06

PEGS Boston Summit
Not Confirmed
PEGS Boston Summit
Not Confirmed

Details : RJx-01 is a combination of galantamine and metformin, works by inhibiting AChE and acting as an allosteric modulator of nAChRs, being investigated for COPD-related muscle weakness.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

May 19, 2025

blank

Details:

Galantamine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.


Lead Product(s): Galantamine Hydrobromide,Striatin

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 16, 2024

blank

07

Dexa Medica

Indonesia
arrow
PEGS Boston Summit
Not Confirmed

Dexa Medica

Indonesia
arrow
PEGS Boston Summit
Not Confirmed

Details : Galantamine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

August 16, 2024

blank

Details:

Essential Pharma has acquired rights to Reminyl (galantamine), a cholinesterase inhibitor, for the EEA, Thailand, South Korea, and other markets, excluding the UK and Japan.


Lead Product(s): Galantamine Hydrobromide,Inapplicable

Therapeutic Area: Neurology Brand Name: Reminyl

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Essential Pharma

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition April 17, 2024

blank

08

PEGS Boston Summit
Not Confirmed
PEGS Boston Summit
Not Confirmed

Details : Essential Pharma has acquired rights to Reminyl (galantamine), a cholinesterase inhibitor, for the EEA, Thailand, South Korea, and other markets, excluding the UK and Japan.

Product Name : Reminyl

Product Type : Miscellaneous

Upfront Cash : Undisclosed

April 17, 2024

blank

Details:

RJx-01, a novel combination drug comprising galantamine and metformin, demonstrated positive results in 42 elderly male subjects with disuse-induced muscle atrophy.


Lead Product(s): Galantamine Hydrobromide,Metformin

Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 04, 2023

blank

09

PEGS Boston Summit
Not Confirmed
PEGS Boston Summit
Not Confirmed

Details : RJx-01, a novel combination drug comprising galantamine and metformin, demonstrated positive results in 42 elderly male subjects with disuse-induced muscle atrophy.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 04, 2023

blank

Details:

RJx-01 is a novel combination of known drugs, there are already extensive safety data available for the constituent compounds. Results will be based on a combination of classic and hi-tech assessment techniques, including data from wearable health tech devices.


Lead Product(s): Galantamine Hydrobromide,Inapplicable

Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 29, 2022

blank

10

PEGS Boston Summit
Not Confirmed
PEGS Boston Summit
Not Confirmed

Details : RJx-01 is a novel combination of known drugs, there are already extensive safety data available for the constituent compounds. Results will be based on a combination of classic and hi-tech assessment techniques, including data from wearable health tech d...

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

March 29, 2022

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATE SUPPLIERS

read-more
read-more

01

PEGS Boston Summit
Not Confirmed
arrow
PEGS Boston Summit
Not Confirmed
arrow

CAS Number : 510-77-0

End Use API : Galantamine Hydrobromide

About The Company : Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - EQ 12MG BASE **Federal...DOSAGE - TABLET;ORAL - EQ 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21169

read-more

DOSAGE - TABLET;ORAL - EQ 4MG BASE **Federal ...DOSAGE - TABLET;ORAL - EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21169

read-more

DOSAGE - TABLET;ORAL - EQ 8MG BASE **Federal ...DOSAGE - TABLET;ORAL - EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21169

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ ...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ 16MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21615

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ ...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ 24MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21615

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ ...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21615

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Direct Compression

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Granulation

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Solubilizers

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Lubricants & Glidants

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Parenteral

read-more
read-more

Topical

read-more
read-more

Co-Processed Excipients

read-more
read-more

Empty Capsules

read-more
read-more

Emulsifying Agents

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Rheology Modifiers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

WEEKLY NEWS RECAP #Phispers

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 1953-04-4 / Galantamine Hydrobromide API manufacturers, exporters & distributors?

Galantamine Hydrobromide manufacturers, exporters & distributors 1

62

PharmaCompass offers a list of Galantamine Hydrobromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Galantamine Hydrobromide manufacturer or Galantamine Hydrobromide supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Galantamine Hydrobromide manufacturer or Galantamine Hydrobromide supplier.

API | Excipient name

Galantamine Hydrobromide

Synonyms

Galanthamine hydrobromide, 1953-04-4, Reminyl, Nivalin, Nivaline, Razadyne

Cas Number

1953-04-4

Unique Ingredient Identifier (UNII)

MJ4PTD2VVW

About Galantamine Hydrobromide

A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders.

Galantamine HBr Manufacturers

A Galantamine HBr manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Galantamine HBr, including repackagers and relabelers. The FDA regulates Galantamine HBr manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Galantamine HBr API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Galantamine HBr manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Galantamine HBr Suppliers

A Galantamine HBr supplier is an individual or a company that provides Galantamine HBr active pharmaceutical ingredient (API) or Galantamine HBr finished formulations upon request. The Galantamine HBr suppliers may include Galantamine HBr API manufacturers, exporters, distributors and traders.

click here to find a list of Galantamine HBr suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Galantamine HBr USDMF

A Galantamine HBr DMF (Drug Master File) is a document detailing the whole manufacturing process of Galantamine HBr active pharmaceutical ingredient (API) in detail. Different forms of Galantamine HBr DMFs exist exist since differing nations have different regulations, such as Galantamine HBr USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Galantamine HBr DMF submitted to regulatory agencies in the US is known as a USDMF. Galantamine HBr USDMF includes data on Galantamine HBr's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Galantamine HBr USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Galantamine HBr suppliers with USDMF on PharmaCompass.

Galantamine HBr JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Galantamine HBr Drug Master File in Japan (Galantamine HBr JDMF) empowers Galantamine HBr API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Galantamine HBr JDMF during the approval evaluation for pharmaceutical products. At the time of Galantamine HBr JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Galantamine HBr suppliers with JDMF on PharmaCompass.

Galantamine HBr KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Galantamine HBr Drug Master File in Korea (Galantamine HBr KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Galantamine HBr. The MFDS reviews the Galantamine HBr KDMF as part of the drug registration process and uses the information provided in the Galantamine HBr KDMF to evaluate the safety and efficacy of the drug.

After submitting a Galantamine HBr KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Galantamine HBr API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Galantamine HBr suppliers with KDMF on PharmaCompass.

Galantamine HBr CEP

A Galantamine HBr CEP of the European Pharmacopoeia monograph is often referred to as a Galantamine HBr Certificate of Suitability (COS). The purpose of a Galantamine HBr CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Galantamine HBr EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Galantamine HBr to their clients by showing that a Galantamine HBr CEP has been issued for it. The manufacturer submits a Galantamine HBr CEP (COS) as part of the market authorization procedure, and it takes on the role of a Galantamine HBr CEP holder for the record. Additionally, the data presented in the Galantamine HBr CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Galantamine HBr DMF.

A Galantamine HBr CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Galantamine HBr CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Galantamine HBr suppliers with CEP (COS) on PharmaCompass.

Galantamine HBr WC

A Galantamine HBr written confirmation (Galantamine HBr WC) is an official document issued by a regulatory agency to a Galantamine HBr manufacturer, verifying that the manufacturing facility of a Galantamine HBr active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Galantamine HBr APIs or Galantamine HBr finished pharmaceutical products to another nation, regulatory agencies frequently require a Galantamine HBr WC (written confirmation) as part of the regulatory process.

click here to find a list of Galantamine HBr suppliers with Written Confirmation (WC) on PharmaCompass.

Galantamine HBr NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Galantamine HBr as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Galantamine HBr API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Galantamine HBr as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Galantamine HBr and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Galantamine HBr NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Galantamine HBr suppliers with NDC on PharmaCompass.

Galantamine HBr GMP

Galantamine HBr Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Galantamine HBr GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Galantamine HBr GMP manufacturer or Galantamine HBr GMP API supplier for your needs.

Galantamine HBr CoA

A Galantamine HBr CoA (Certificate of Analysis) is a formal document that attests to Galantamine HBr's compliance with Galantamine HBr specifications and serves as a tool for batch-level quality control.

Galantamine HBr CoA mostly includes findings from lab analyses of a specific batch. For each Galantamine HBr CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Galantamine HBr may be tested according to a variety of international standards, such as European Pharmacopoeia (Galantamine HBr EP), Galantamine HBr JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Galantamine HBr USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty